medigraphic.com
Colegio de Medicina Interna de México.

2012, Number 2

<< Back Next >>

Med Int Mex 2012; 28 (2)

Gallbladder disease as a manifestation of Weil's disease. Report of a case where a resident of Mexico City

Córdova PVH, Vega LCA, Vera UR, León MG, Calva MJJ, Soto NGI, Candelaria HMG, Chirino RJ

Language: Spanish
References: 28
Page: 196-201
PDF size: 298.86 Kb.


ABSTRACT

Leptospirosis is a worldwide zoonosis disease. The 90% of the cases corresponds to the anicteric form and 10% of the cases to the icteric form or Weil's disease.
One of the manifestations of Weil's disease is in the liver which is characterized by increased serum bilirubin and moderate increase in transaminases and alkaline phosphatase. Weil's disease can mimic cholecystitis and have been reported cases of acute acalculous cholecystitis as a rare manifestation of leptospirosis in adults.
We present the case of a 42 year old man who was attended at the Internal Medicine ward of the Hospital “Angeles del Pedregal” because of clinical symptoms characterized by myalgias, arthralgias, headache and fever. During his stay he had a clinical picture, laboratory and imaging consistent with acalculous cholecystitis, he was underwent a surgical procedure and with suspicion of Weil syndrome we initiated management with doxycycline and the serology for Leptospira interrogans confirmed the diagnosis and evolved towards improvement. Weil's disease can mimic a clinical picture similar to acute cholecystitis, so it must be considered if risk factors for acquiring the disease.


REFERENCES

  1. Weil A. Über eine eigentümliche, mit Milztumor, Icterus und Nephritis einhergehende, acute Infectionskrankheit. Deutsche Archive für Klinische Medizin 1886;39:209.

  2. Alston JM, Brown HC. The Epidemiology of Weil's Disease. Proc R Soc Med 1937;30(6): 741-756.

  3. Erosa BA. Leptopirosis. Rev Biomed 2001;12:282-287.

  4. Cachay ER, Vinetz JM. A global research agenda for leptospirosis. J Postgrad Med 2005;51:174-178.

  5. Leptospirosis: an emerging public health problem. Wkly Epidemiol Rec 2011;86(6):45-50.

  6. Noguchi H, Klieger J. Immunological studies with a strain of Leptospira isolated from a case of yellow fever in Mérida, Yucatán. J Exp Med 1920(32):67-70.

  7. Vado-Solís IA, Cárdenas-Marrufo MF, Laviada-Molina H y col. Estudio de casos clínicos e incidencia de leptospirosis humana en el estado de Yucatán, México, durante el periodo 1998 a 2000. Rev Biomed 2002;13:157-164.

  8. Sistema Único de Información para la Vigilancia Epidemiológica. Casos por entidad federativa de Enfermedades Zoonóticas hasta la semana epidemiológica 6 del 2011. Dirección General de Epidemiologia de la Secretaría de Salud de los Estados Unidos Mexicanos.

  9. Slack A. Leptospirosis. Aust Fam Physician 2010;39(6):495-498.

  10. Carrada-Bravo T. Leptospirosis humana. Historia natural, diagnóstico y tratamiento. Rev Mex Patol Clin 2005;52(4):246-256.

  11. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 2003;3:755-769.

  12. Borbolla-Sala, Manuel E, y col. Leptospirosis durante la contingencia ambiental por inundación en Tabasco 2008. Salud Tab 2009;15(2-3):860-867.

  13. Adler B, De La Peña A. Leptospira and leptospirosis. Vet Microbiol 2010;140:287-296.

  14. Cinco M. New insights into the pathogenicity of leptospires: evasion of host defences. New Microbiologica 2010;33:283-292.

  15. Medeiros FDR, Spichler A, Athanazio DA. Leptospirosis-associated disturbances of blood vessels, lungs and hemostasis. Acta Tropical 2010;115(1-2):155-162.

  16. Farr RW. Leptospirosis. Clin Infect Dis 1995;21:1-8.

  17. Anton Aranda E. Colecistitis alitiásica aguda asociada con leptospirosis. Rev Esp Enferm Dig 2001; 93(11):740-746.

  18. Van Breda Vriesman AC, Engelbrecht MR, Smithuis RH, Puylaert JB. Diffuse gallbladder wall thickening: differential diagnosis. AJR Am J Roentgenol 2007;188:495-501.

  19. Edwards CN, Nicholson GD, Everard CO. Thrombocytopenia in leptospirosis. Am J Trop Med Hyg 1982;31:827-829.

  20. Chierakul W, Tientadakul P, Suputtamongkol Y, et al. Activation of the coagulation cascade in patients with leptospirosis. Clin Infect Dis 2008;46(2):254-260.

  21. Abdulkader RCRM, Silva MV. The kidney in leptospirosis. Pediatr Nephrol 2008;23:2101-2120.

  22. Norma Oficial Mexicana NOM-029-SSA2-1999 para la vigilancia epidemiológica, prevención y control de la leptospirosis en el humano.

  23. WHO/ILS. Leptospirosis Humana: Guía para el Diagnóstico, Vigilancia y Control (en Castellano, 2008).

  24. Watt G, Padre LP, Tuazon ML, et al. Placebo controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet 1988;1:433-435.

  25. Brett-Major DM, Lipnick RJ. Antibiotic prophylaxis for leptospirosis. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD007342.

  26. Velasco-Castrejón O, Rivas-Sánchez B, Sánchez SME, Soriano J, Rivera RHH, Garibay SV. Leptospirosis crónica en México: diagnóstico microscópico y evidencias que respaldan su existencia e importancia. Rev Mex Patol Clin 2009;56:157-167.

  27. Dupont H, et al. Leptospirosis: prognostic factors associated with mortality. Clin Infect Dis 1997;25:720-724.

  28. Koizumi N, Watanabe H. Leptospirosis vaccines: Past, present, and future. J Postgrad Med 2005;51(3):210-214.




2020     |     www.medigraphic.com